Background: This meta-analysis was conducted to analyze the correlations of OX40 ligand (OX40L) variants with atherosclerotic cardio-cerebral vascular diseases (ASCVD). Methods: Systematic literature research was conducted in PubMed, Medline, and Embase. All statistical analyses were conducted with Review Manager. Results: Totally eighteen studies were enrolled for analyses. Although no any significant correlations between OX40L variants and ASCVD were detected in overall analyses. Further subgroup analyses by ethnicity revealed that rs1234314 variant was significantly associated with ASCVD in East Asians (dominant model: P = 0.03, odds ratios [OR] = 1.15, 95% confidence interval [CI], 1.01-1.31; allele model: P = 0.04, OR = 1.10, 95%CI, 1.00-1.20). When we stratified eligible studies by type of disease, positive results were observed for rs17568 variant in subjects with acute coronary syndrome (ACS) (allele model: P = 0.04, OR = 0.81, 95%CI, 0.65-0.99), for rs1234314 variant in subjects with coronary artery disease (CAD) (dominant model: P = 0.04, OR = 1.16, 95%CI, 1.00-1.35), for rs3850641 variant in subjects with CAD (recessive model: P = 0.02, OR = 1.42, 95%CI, 1.05-1.90) and myocardial infarction (MI) (recessive model: P = 0.03, OR = 1.49, 95%CI, 1.05-2.11).Conclusions: Our findings suggested that rs17568, rs1234314, and rs3850641 variants might serve as genetic biomarkers of certain types of CAD. K E Y W O R D S atherosclerotic cardio-cerebral vascular diseases (ASCVD), coronary artery disease (CAD), genetic variants, ischemic stroke (IS), meta-analysis, OX40 ligand (OX40L) F I G U R E 1 Flowchart of study selection for the present study WANG ET AL. | 9625
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.